Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/163029
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCarrillo Sánchez, Carolina-
dc.contributor.authorSánchez Hernández, Noemí-
dc.contributor.authorGarcía Montoya, Encarna-
dc.contributor.authorPérez Lozano, Pilar-
dc.contributor.authorTicó Grau, Josep R.-
dc.contributor.authorSuñé i Negre, Josep M. (Josep Maria)-
dc.contributor.authorSuñé, Carlos-
dc.contributor.authorMiñarro Carmona, Montserrat-
dc.date.accessioned2020-05-29T09:13:00Z-
dc.date.available2020-05-29T09:13:00Z-
dc.date.issued2013-02-27-
dc.identifier.issn0928-0987-
dc.identifier.urihttp://hdl.handle.net/2445/163029-
dc.description.abstractIn recent years the use of solid lipid nanoparticles (SLNs) as transport systems for the delivery of drugs and biomolecules has become particularly important. The use of cationic SLNs developed by the technique of microemulsion, which are complexed with DNA in order to study their application as non-viral vectors in gene therapy, is reported. The nanoparticles are characterized by scanning electron microscopy and transmission electron microscopy (SEM and TEM), atomic force microscopy (AFM) and differential scanning calorimetry (DSC). Furthermore, the process of lyophilization of the samples and their stability was studied. The nanoparticles obtained presented a particle size of 340 nm with a positive surface charge of 44 mV and the capability of forming lipoplexes with DNA plasmids was stated.-
dc.format.extent9 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherElsevier B.V.-
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1016/j.ejps.2013.02.011-
dc.relation.ispartofEuropean Journal of Pharmaceutical Sciences, 2013, vol. 49, num. 2, p. 157-165-
dc.relation.urihttps://doi.org/10.1016/j.ejps.2013.02.011-
dc.rights(c) Elsevier B.V., 2013-
dc.sourceArticles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)-
dc.subject.classificationDispositius d'administració de medicaments-
dc.subject.classificationNanopartícules-
dc.subject.classificationTeràpia genètica-
dc.subject.classificationBiomolècules-
dc.subject.otherDrug delivery devices-
dc.subject.otherNanoparticles-
dc.subject.otherGene therapy-
dc.subject.otherBiomolecules-
dc.titleDNA delivery via cationic solid lipid nanoparticles (SLNs)-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/acceptedVersion-
dc.identifier.idgrec620742-
dc.date.updated2020-05-29T09:13:00Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid23454134-
Appears in Collections:Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)

Files in This Item:
File Description SizeFormat 
620742.pdf1.86 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.